SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Lexaria Bioscience Corp. Common Stock

LEXX XNAS
$4.03 -0.46 (-10.24%) ▼ 15-min delayed
Open
$4.51
High
$4.51
Low
$4.03
Volume
32.9K
Market Cap
$8.49M

About Lexaria Bioscience Corp. Common Stock

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 7 Website →

Related Market News

No specific coverage for LEXX yet. Check out our latest market news or earnings calendar.

Get LEXX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lexaria Bioscience Corp. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.